CVS Claims GLP‑1 Drugs Cut Costs If Priced Under $350 a Month
CVS reports that GLP‑1 medications can save money for patients when monthly prices stay below $350, highlighting a potential cost‑benefit threshold.
POLICY WIRE — New York, USA — CVS Health stated that GLP‑1 medications could produce net savings for patients if the monthly price remains under $350.
The company highlighted that keeping the price below this level would make the drugs financially advantageous compared with alternative treatments.
CVS did not disclose the specific analytical method or name particular GLP‑1 products in its brief comment.
Further details on how the savings calculation was derived were not provided.
Reporting by Policy-Wire (PW)



